NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference
January 27, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
January 11, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
December 16, 2021 07:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Third Quarter 2021 Financial Results
November 10, 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
November 10, 2021 16:02 ET
|
NeuroPace, Inc.
IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation to treat primary generalized epilepsy in patients aged 12 and older MOUNTAIN VIEW, Calif., Nov. 10, 2021 ...
NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021
October 20, 2021 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Announces Addition of Lisa Andrade to the Board
October 19, 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc., (Nasdaq:NPCE) a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today...
NeuroPace to Participate in Upcoming Conferences
August 23, 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Second Quarter 2021 Financial Results
August 12, 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
July 22, 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...